Department of Pediatrics, The Central Hospital of Kaifeng City, Kaifeng, Henan, China.
Department of Pediatrics, The Central Hospital of Kaifeng City, Kaifeng, Henan, China.
Biomed Pharmacother. 2019 Dec;120:109385. doi: 10.1016/j.biopha.2019.109385. Epub 2019 Sep 19.
Long non-coding RNA (lncRNA) linc00152 has been recognized as an oncogenic lncRNA in various cancers. This study attempts to investigate the roles of linc00152 in the metastasis-related traits of infantile hemangioma (IH). Linc00152 was overexpressed in the proliferating-phase hemangioma tissues when compared with that in involuting-phase. Downregulation of linc00152 strikingly suppressed the cell viability, migration and invasion of hemangioma cells. Furthermore, silence of linc00152 repressed the growth and lung metastasis of hemangioma cell in vivo. Subsequent analysis revealed that linc00152 bound with miR-139-5p and linc00152 expression was inversely correlated with the level of miR-139-5p in IH. Same effects of miR-139-5p transfection on HemECs cells were observed as downregulation of linc00152. Moreover, tumor protein D52 (TPD52) was confirmed to be the target of miR-139-5p. Besides, the anti-tumor effect of linc00152 silence on hemangioma cell was reversed by rexpression of TPD52. This study demonstrates that downregulatuon of linc00152 restrains the aggressiveness of hemangioma cell in vitro and in vivo via interacting with miR-139-5p and further modulates the level of TPD52.
长链非编码 RNA(lncRNA)linc00152 已被认为是多种癌症中的致癌 lncRNA。本研究试图探讨 linc00152 在婴儿血管瘤(IH)转移相关特征中的作用。与退化期相比,增殖期的血管瘤组织中 linc00152 表达上调。下调 linc00152 显著抑制了血管瘤细胞的活力、迁移和侵袭。此外,沉默 linc00152 抑制了体内血管瘤细胞的生长和肺转移。随后的分析表明,linc00152 与 miR-139-5p 结合,linc00152 的表达与 IH 中 miR-139-5p 的水平呈负相关。miR-139-5p 转染对 HemECs 细胞的相同影响与下调 linc00152 观察到的结果一致。此外,肿瘤蛋白 D52(TPD52)被证实是 miR-139-5p 的靶标。此外,linc00152 沉默对血管瘤细胞的抗肿瘤作用被 TPD52 的过表达逆转。本研究表明,下调 linc00152 通过与 miR-139-5p 相互作用,在体外和体内抑制了血管瘤细胞的侵袭性,并进一步调节了 TPD52 的水平。